 |
|
|
|
|
|
|
Das A, Jr, et al.
Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis.
Osteoarthritis Cartilage. 2000 Sep;8(5):343-50.
|
|
Leffler CT, et al.
Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study.
Mil Med. 1999 Feb;164(2):85-91.
|
|
Nguyen P, et al.
A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study.
Cranio. 2001 Apr;19(2):130-9.
|
|
Shankland WE.
The effects of glucosamine and chondroitin sulfate on osteoarthritis of the TMJ: a preliminary report of 50 patients.
J Craniomandib Practice 1998;16:230-35.
|
Back to Top |
|
|
|
|
|
|
 |
GAIT Study |
|
|
|
|
GUIDE Study |
|
|
|
|
 |
|
Who Owns This Joint?
by David A. Mark, Ph.D. |
|
|
David A. Mark, Ph.D. is President of dmark consulting LLC, a firm specializing in research management services for the functional food, food ingredient, dietary supplement and performance nutrition industries.
Read more about David A. Mark, Ph.D. |
|
|
|
|
